Missing/wrong data?
Log in to edit
Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma.
scientific article published on 23 January 2018
Author/s
author: Patrice N. Marche, Gaël S Roth, Brian Schwartz, Pierre Hainaut, Thomas Decaens
Work details
Publication date
January 23, 2018
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.